Concordance of Post-consolidation Minimal Residual Disease Rates by Multiparametric Flow Cytometry and Next-generation Sequencing in CASSIOPEIA

被引：16

作者：

Avet-Loiseau, Herve ^{[1
]}

Bene, Marie C. ^{[2
]}

Wuilleme, Soraya ^{[2
]}

Corre, Jill ^{[1
]}

Attal, Michel ^{[3
]}

Arnulf, Bertrand ^{[4
]}

Garderet, Laurent ^{[5
]}

Macro, Margaret ^{[6
]}

Stoppa, Anne-Marie ^{[7
]}

Delforge, Michel ^{[8
]}

Broijl, Annemiek ^{[9
]}

Zweegman, Sonja ^{[10
]}

Jie, Kon-Siong ^{[11
]}

Van de Donk, Niels ^{[12
]}

Pei, Lixia ^{[13
]}

de Boer, Carla ^{[14
]}

Chiu, Chris ^{[15
]}

Vanquickelberghe, Veronique ^{[16
]}

Kampfenkel, Tobias ^{[14
]}

Vermeulen, Jessica ^{[14
]}

Moreau, Philippe ^{[17
]}

Sonneveld, Pieter ^{[9
]}

机构：

[1] IUC T Oncopole, Unite Genom Myelome, Toulouse, France

[2] Univ Hosp Hotel Dieu, Hematol Biol, Nantes, France

[3] Inst Univ Canc Toulouse Oncopole, Toulouse, France

[4] Hop St Louis, Hematol Oncol, Paris, France

[5] Sorbonne Univ, INSERM, Paris, France

[6] CHU Caen, Caen, France

[7] Inst Paoli Calmettes, Marseille 9, France

[8] Univ Ziekenhuizen Leuven, Leuven, Belgium

[9] Erasmus MC Canc Inst, Rotterdam, Netherlands

[10] Vrije Univ Amsterdam, Amsterdam UMC, Dept Hematol, Amsterdam, Netherlands

[11] Zuyderland MC, Sittard, Netherlands

[12] Vrije Univ Amsterdam Med Ctr, Dept Hematol, Amsterdam, Netherlands

[13] Janssen Res & Dev LLC, Raritan, NJ USA

[14] Janssen Res & Dev LLC, Leiden, Netherlands

[15] Janssen Res & Dev LLC, Spring House, PA USA

[16] Janssen Res & Dev, Beerse, Belgium

[17] Univ Hosp Hotel Dieu, Hematol, Nantes, France

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期

关键词：

daratumumab; Multiple myeloma; transplant;

D O I：

10.1016/j.clml.2019.09.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OAB-004

引用

页码：E3 / E4

页数：2

共 50 条

[1] Comparison of Next-Generation Flow Cytometry (NGF) and Next-Generation Sequencing (NGS) in the Assessment of Minimal Residual Disease in Multiple Myeloma
Wang, Qingqing
Yao, Li
Zhu, Mingqing
Yan, Lingzhi
Jin, Song
Shang, Jingjing
Shi, Xiaolan
Zhai, Yingying
Yan, Shuang
Yao, Weiqin
You Hongying
Wu, Depei
Fu, Chengcheng
BLOOD, 2022, 140 : 7249 - 7250
[2] Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myeloma
Zhou, Mo
Chen, Yan
Gong, Yanlei
Zhu, Mingqing
Cen, Jiannong
Pan, Jinlan
Yan, Lingzhi
Shang, Jingjing
Jin, Song
Shi, Xiaolan
Yao, Weiqin
Yan, Shuang
Wu, Depei
Chen, Suning
Fu, Chengcheng
Yao, Li
DISCOVER ONCOLOGY, 2024, 15 (01)
[3] Evaluation of next-generation sequencing versus next-generation flow cytometry for minimal-residual-disease detection in Chinese patients with multiple myeloma
Mo Zhou
Yan Chen
Yanlei Gong
Mingqing Zhu
Jiannong Cen
Jinlan Pan
Lingzhi Yan
Jingjing Shang
Song Jin
Xiaolan Shi
Weiqin Yao
Shuang Yan
Depei Wu
Suning Chen
Chengcheng Fu
Li Yao
Discover Oncology, 15
[4] Comparison of Measurable Residual Disease in Pediatric B-Lymphoblastic Leukemia Using Multiparametric Flow Cytometry and Next-Generation Sequencing
Hwang, Sang Mee
Oh, Inseong
Kwon, Seok Ryun
Lee, Jee-Soo
Seong, Moon -Woo
ANNALS OF LABORATORY MEDICINE, 2024, 44 (04) : 354 - 358
[5] Measurable Residual Disease in Adult B Lymphoblastic Leukemia: A Study of Concordance between Multiparametric Flow Cytometry, Next-Generation Sequencing of Immunoglobulin Gene Rearrangements, and Quantitative PCR
Jung, Jin
Yoon, Jae-Ho
Lee, Seok
Ahn, Ari
Lee, Jong-Mi
Kim, Yonggoo
Kim, Myungshin
BLOOD, 2024, 144 : 1468 - 1469
[6] Next-generation sequencing for measuring minimal residual disease in AML
Walter, Roland B.
Appelbaum, Frederick R.
NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (08) : 473 - 474
[7] Next-generation sequencing for measuring minimal residual disease in AML
Roland B. Walter
Frederick R. Appelbaum
Nature Reviews Clinical Oncology, 2018, 15 : 473 - 474
[8] Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis
Efstathios Kastritis
Ioannis V. Kostopoulos
Evangelos Terpos
Bruno Paiva
Despina Fotiou
Maria Gavriatopoulou
Nikolaos Kanellias
Dimitrios C. Ziogas
Maria Roussou
Magdalini Migkou
Evangelos Eleutherakis-Papaiakovou
Ioannis P. Trougakos
Ourania Tsitsilonis
Meletios A. Dimopoulos
Blood Cancer Journal, 8
[9] Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis
Kastritis, Efstathios
Kostopoulos, Ioannis V.
Terpos, Evangelos
Paiva, Bruno
Fotiou, Despina
Gavriatopoulou, Maria
Kanellias, Nikolaos
Ziogas, Dimitrios C.
Roussou, Maria
Migkou, Magdalini
Eleutherakis-Papaiakovou, Evangelos
Trougakos, Ioannis P.
Tsitsilonis, Ourania
Dimopoulos, Meletios A.
BLOOD CANCER JOURNAL, 2018, 8
[10] Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
Alejandro Medina
Noemi Puig
Juan Flores-Montero
Cristina Jimenez
M.-Eugenia Sarasquete
María Garcia-Alvarez
Isabel Prieto-Conde
Carmen Chillon
Miguel Alcoceba
Norma C. Gutierrez
Albert Oriol
Laura Rosinol
Joan Bladè
Mercedes Gironella
Miguel T. Hernandez
Veronica Gonzalez-Calle
Maria-Teresa Cedena
Bruno Paiva
Jesus F. San-Miguel
Juan-Jose Lahuerta
Maria-Victoria Mateos
Joaquin Martinez-Lopez
Alberto Orfao
Marcos Gonzalez
Ramon Garcia-Sanz
Blood Cancer Journal, 10

← 1 2 3 4 5 →